Enzo Biochem files suit against eight Life Science companies. (Executive Briefing).
Enzo claims infringement shortly after the agreements were signed, thus a ruling in favor of Enzo involving damages could have a substantial financial effect on the defendants. Enzo Biochem has previously brought patent infringement suits against Calgene, Gen Probe and Digene. The ruling in the Digene case earlier this year invalidated Enzo' patents due to a "lack of written description," raising questions as to the validity of some current biotech patents. In August, the US Court of Appeals reversed the decision and the case will be reheard.
|Printer friendly Cite/link Email Feedback|
|Comment:||Enzo Biochem files suit against eight Life Science companies. (Executive Briefing).|
|Publication:||Instrument Business Outlook|
|Article Type:||Brief Article|
|Date:||Oct 31, 2002|
|Previous Article:||PerkinElmer combines Life Science and Analytical Instrument businesses. (Executive Briefing).|
|Next Article:||Fisher Scientific and VWR increase product offerings for Europe. (Executive Briefing).|